[U.S. Food
and Drug  Administration]

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policymakers with persons outside the executive branch of the Federal Government.

Week of May 15 - May 21, 1998

FDA Official and Title Date and SiteOther FDA ParticipantsNon-FDA ParticipantsSubject
Michael A. Friedman, M.D. Lead Deputy Commissioner 5/11 Washington, DC None Dr. Jordan Cohen, David Korn, Richard Knapp (Assn. Of American Medical Colleges) General Discussion (no minutes available)
Michael A. Friedman, M.D. Lead Deputy Commissioner 5/14 FDA-Pkln Kathy Vengazo, Office of Human Resources & Mgmt. Services and many many others Union Members Introduction of the Lead Deputy Commissioner (no minutes available)
Dr. Stuart L. Nightingale, Associate Commissioner for Health Affairs 5/11-16 Geneva, Switzerland none Secretary Shalala, Dr. Satcher, and other members of the U.S. Delegation and delegations from WHO member countries World Health Assembly
Dr. Stuart L. Nightingale, Associate Commissioner for Health Affairs 5/19 Cleveland, Ohio Glen Drew Members of the National Bioethics Advisory Commission FDA's Role in Human Subject Protection in Foreign Clinical Trials
Dr. Stuart L. Nightingale, Associate Commissioner for Health Affairs 5/21 Rockville, Maryland Peter Rheinstein, Robert DeLap, Patricia Keegan, and others Dr. William McGivney, National Comprehensive Cancer Network (NCCN); Jack Gentile, Fay Symons, PRR NCCN Oncology Outcomes Database
Dr. Stuart L. Nightingale, Associate Commissioner for Health Affairs 5/21 Rockville, Maryland Nick Reuter, Michael Kleim, Silvia Calederon Dr. Michael Young, Medeva, PLC; Robert Dormer, & others, NIDA Quotas for methylphenidate
Kathryn C. Zoon, Ph.D., Director, CBER 5/22 Washington, DC None known Attendees at Conference DIA Workshop on Electronic Submissions Electronic Submissions
David Feigal, M.D., Deputy for Medicine, CBER 5/15 Bethesda, MD None Members, American Blood Resources Association (ABRA) Discuss ABRA presentation at BPAC
David Feigal, M.D., Deputy for Medicine, CBER 5/19 Bethesda, MD None Thermogenesis, Executive Officer Review of blood devices
David Feigal, M.D., Deputy for Medicine, CBER 5/21 Bethesda, MD None Attendees at Conference CDC/NIH/WHO workshop on preclinical evaluation of topical virucides. Chair of Working Group on Topicall Microbicides
David Feigal, M.D., Deputy for Medicine, CBER 5/22 Bethesda, MD None University of Rhode Island School of Pharmacy Representative Plan for meeting for blood banks on quality assurance programs
Joseph A. Levitt Director, CFSAN 5/19 Room 6821 Catherine Carnevale Dr. George Paterson, Health Protection Branch, Health Canada Courtesy visit
Janice F. Oliver Deputy Director for Systems & Support 5/15 Room 6821 Carl Reynolds, Lee Bowers, LeeAnne Jackson, Ellen Morrison United Fresh Fruits & Vegetables Assoc. (UFFVA) Stacy Zaawel, John Aguirre Tracebacks

Return to FDA News Page

May 18, 1998